# Interpace Biosciences Posts $10.4 Million in Q3 Revenue, $0.26 GAAP Loss Per Share

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/58873
Published: 2026-11-16T22:28:59.000Z
Updated: 2026-11-16T22:28:59.000Z
Section: Business

> Revenue increased 18.7% from the year-earlier quarter.

Interpace Biosciences generated $10.4 million in revenue for the third quarter, an 18.7% increase from the same period a year earlier.

The company recorded a GAAP loss of $0.26 per share for the quarter.


